000 | 01785 a2200517 4500 | ||
---|---|---|---|
005 | 20250516103238.0 | ||
264 | 0 | _c20140407 | |
008 | 201404s 0 0 eng d | ||
022 | _a1573-2584 | ||
024 | 7 |
_a10.1007/s11255-012-0241-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElmas, Ahmet Taner | |
245 | 0 | 0 |
_aShort- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome. _h[electronic resource] |
260 |
_bInternational urology and nephrology _cAug 2013 |
||
300 |
_a1047-55 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney Function Tests |
650 | 0 | 4 |
_aLevamisole _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNephrotic Syndrome _xdiagnosis |
650 | 0 | 4 | _aPatient Safety |
650 | 0 | 4 |
_aProteinuria _xprevention & control |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSecondary Prevention |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aSteroids _xadverse effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTabel, Yılmaz | |
700 | 1 | _aElmas, Ozlem Nalbantoğlu | |
773 | 0 |
_tInternational urology and nephrology _gvol. 45 _gno. 4 _gp. 1047-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11255-012-0241-x _zAvailable from publisher's website |
999 |
_c21969594 _d21969594 |